Try Premium for 30 days

Live games for all NFL, MLB, NBA, & NHL teams
Commercial-Free Music
No Display Ads
Cystic Fibrosis in Focus-logo

Cystic Fibrosis in Focus

ReachMD

More Information

Location:

United States

Networks:

ReachMD

Language:

English


Episodes

Cystic Fibrosis: The Essential Role of Pancreatic Enzyme Replacement Therapy in Patient Care

12/12/2016
More
Host: John J. Russell, MD Guest: Suzanne Michel, MPH, RD, LDN Approximately 85-90% of patients with Cystic Fibrosis suffer from pancreatic insufficiency since birth, which significantly complicates the disease and adversely affects both quality of life and life expectancy. Join Professor Suzanne Michele, registered dietitian, as she discusses supplemental enzymes and their role in the health of persons who have CF, the barriers to adherence with pancreatic enzyme replacement therapy, and...

Duration: 00:18:29


Nontuberculous Mycobacteria (NTM) in Patients with Cystic Fibrosis

11/22/2016
More
Host: John J. Russell, MD Guest: Patrick Flume, MD Nontuberculous mycobacteria infection of the lung (a.k.a. NTM lung disease) is becoming increasingly common. In this activity, we are going to discuss how patients are evaluated and treated, as well as potential complications to be aware of in the management of NTM lung disease. Commercial Support:No commercial support has been provided for this activity.

Duration: 00:11:29


Chronic Care Challenges with Cystic Fibrosis

11/11/2016
More
Host: Barnett Mennen, MD Guest: Peter J. Mogayzel, Jr, MD, PhD, MBA This activity discusses the etiology of cystic fibrosis lung disease, the current clearance approaches and the role CFTR modulator therapy in the treatment of cystic fibrosis lung disease, and the relationship between lung function and nutritional status in cystic fibrosis.

Duration: 00:13:29


Lung Transplantation for Cystic Fibrosis

10/26/2016
More
Host: Barnett Mennen, MD Guest: Denis Hadjiliadis, MD, MHS, PhD Lung Transplantation is often considered for patients with cystic fibrosis. In this activity, we will discuss how patients are evaluated and listed, common complications, medications that are used, and survival after lung transplantation.

Duration: 00:18:29


Cell Death and Differentiation: A Novel Treatment of Cystic Fibrosis Acting On-Target

8/1/2016
More
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR. Tosco A, De Gregorio F, Esposito S, De Stefano D, Sana I, Ferrari E, Sepe A, Salvadori L, Buonpensiero P, Di Pasqua A, Grassia R, Leone CA,Guido S, De Rosa G, Lusa S, Bona G, Stoll G, Maiuri MC, Mehta A, Kroemer G, Maiuri L, Raia V. Cell Death Differ. 2016 Aug;23(8):1380-93. doi: 10.1038/cdd.2016.22. Epub 2016 Apr 1. AbstractWe...

Duration: 00:03:30


Journal of Cystic Fibrosis: Microbial Colonization and Lung Function in Adolescents With Cystic Fibrosis

8/1/2016
More
Microbial colonization and lung function in adolescents with cystic fibrosis. Hector A, Kirn T, Ralhan A, Graepler-Mainka U, Berenbrinker S, Riethmueller J, Hogardt M, Wagner M, Pfleger A, Autenrieth I, Kappler M, Griese M, Eber E, Martus P, Hartl D. J Cyst Fibros. 2016 May;15(3):340-9. doi: 10.1016/j.jcf.2016.01.004. Epub 2016 Feb 5. Abstract With intensified antibiotic therapy and longer survival, patients with cystic fibrosis (CF) are colonized with a more complex pattern ofbacteria and...

Duration: 00:02:30


Journal of Cystic Fibrosis: Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients

8/1/2016
More
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients. Flume PA, VanDevanter DR, Morgan EE, Dudley MN, Loutit JS, Bell SC, Kerem E, Fischer R, Smyth AR, Aaron SD, Conrad D, Geller DE,Elborn JS. J Cyst Fibros. 2016 Jul;15(4):495-502. doi: 10.1016/j.jcf.2015.12.004. Epub 2016 Feb 4. Abstract RATIONALE: For patients with cystic fibrosis...

Duration: 00:03:30